|
Better outcomes for her2+ hormonal positives....
Identification of a low risk subgroup in Her2-positive breast cancer by the 70-gene prognosis signature...
http://www.abstracts2view.com/sabcs/...8L_1453&terms=
"The good prognosis group had positive hormone-receptors in 85%, and fewer patients received adjuvant therapy: 16 patients (59%) received no adjuvant treatment, 6 (22%) received adjuvant chemotherapy, 8 (30%) hormonal therapy and 1 (4%) received trastuzumab."
__________________
Robin
2002- dx her2 positive DCIS/bc TX Mast, herceptin chemo
|
Threaded Mode